JPWO2022081997A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022081997A5 JPWO2022081997A5 JP2023522978A JP2023522978A JPWO2022081997A5 JP WO2022081997 A5 JPWO2022081997 A5 JP WO2022081997A5 JP 2023522978 A JP2023522978 A JP 2023522978A JP 2023522978 A JP2023522978 A JP 2023522978A JP WO2022081997 A5 JPWO2022081997 A5 JP WO2022081997A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- acid sequence
- seq
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063093029P | 2020-10-16 | 2020-10-16 | |
| US63/093,029 | 2020-10-16 | ||
| PCT/US2021/055216 WO2022081997A1 (en) | 2020-10-16 | 2021-10-15 | Compositions and methods for treating blood disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545501A JP2023545501A (ja) | 2023-10-30 |
| JP2023545501A5 JP2023545501A5 (https=) | 2024-10-22 |
| JPWO2022081997A5 true JPWO2022081997A5 (https=) | 2024-10-22 |
Family
ID=81208704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522978A Pending JP2023545501A (ja) | 2020-10-16 | 2021-10-15 | 血液障害を処置するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230391858A1 (https=) |
| EP (1) | EP4228696A4 (https=) |
| JP (1) | JP2023545501A (https=) |
| KR (1) | KR20230087572A (https=) |
| AU (1) | AU2021361067A1 (https=) |
| CA (1) | CA3195798A1 (https=) |
| MX (1) | MX2023004429A (https=) |
| WO (1) | WO2022081997A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015006507A1 (en) | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| WO2023114763A1 (en) * | 2021-12-13 | 2023-06-22 | Annexon, Inc. | Anti-complement factor c1q antibodies with single binding arms and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015006507A1 (en) * | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| HUE070383T2 (hu) * | 2014-11-05 | 2025-06-28 | Annexon Inc | Humanizált C1Q anti-komplement faktor antitestek és alkalmazásaik |
| WO2017091719A1 (en) * | 2015-11-24 | 2017-06-01 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
| WO2021076991A1 (en) * | 2019-10-17 | 2021-04-22 | Annexon, Inc. | Compositions and methods for treating blood disorders |
-
2021
- 2021-10-15 CA CA3195798A patent/CA3195798A1/en active Pending
- 2021-10-15 US US18/032,084 patent/US20230391858A1/en active Pending
- 2021-10-15 EP EP21881186.7A patent/EP4228696A4/en active Pending
- 2021-10-15 WO PCT/US2021/055216 patent/WO2022081997A1/en not_active Ceased
- 2021-10-15 JP JP2023522978A patent/JP2023545501A/ja active Pending
- 2021-10-15 AU AU2021361067A patent/AU2021361067A1/en active Pending
- 2021-10-15 MX MX2023004429A patent/MX2023004429A/es unknown
- 2021-10-15 KR KR1020237016264A patent/KR20230087572A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7775358B2 (ja) | 単一ドメイン血清アルブミン結合タンパク質 | |
| US10618976B2 (en) | SIRP-α agonist antibody | |
| JP2018520139A (ja) | エクリズマブまたはエクリズマブバリアントでのワクチン接種に従って患者を処置するための方法 | |
| JP2020511469A5 (https=) | ||
| JP2021501134A5 (https=) | ||
| KR20190104982A (ko) | C5-관련 질환의 치료 또는 예방용 의약 조성물 및 c5-관련 질환을 치료 또는 예방하기 위한 방법 | |
| CN1938047A (zh) | 治疗溶血性疾病的方法 | |
| JP2021526534A5 (https=) | ||
| JP2021510736A5 (https=) | ||
| JP2019513726A5 (https=) | ||
| US11760810B2 (en) | Modified immunoglobulin hinge regions to reduce hemagglutination | |
| JPWO2021076991A5 (https=) | ||
| JPWO2022081997A5 (https=) | ||
| JPWO2020154626A5 (https=) | ||
| CN114828886A (zh) | 因子h增强抗体及其用途 | |
| JP2023526051A (ja) | 発作性夜間ヘモグロビン尿症の処置のための補体ｄ因子阻害剤の単独又は抗ｃ５抗体との組み合わせでの使用 | |
| CN116440263A (zh) | 抗ctla-4抗体药物组合物及其用途 | |
| CN115697406A (zh) | 抗体配制品及其用途 | |
| JPWO2022246154A5 (https=) | ||
| JP7735545B2 (ja) | Ｃｄｃプラットホーム抗体 | |
| JPWO2022011086A5 (https=) | ||
| WO2025045251A2 (en) | Multispecific constructs comprising anti-factor d moiety | |
| WO2007002571A2 (en) | Use of an anti c5 complement antibody to treat patients with sickle cell disease | |
| JPWO2022215054A5 (https=) | ||
| AU2023318755A1 (en) | Anti- il27r antibodies and methods of use thereof |